Luengo-Gil相关文献与解析，生知库 | 链接生命科学的每一步

Postigo-Corrales, Fátima; Beltrán-Videla, Asunción; Lázaro-Sánchez, Antonio David; Hurtado, Ana María; Conesa-Zamora, Pablo; Arroyo, Ana Belén; Luengo-Gil, Ginés

肿瘤

肿瘤免疫

乳腺癌

发表日期：2025

文献求助收藏

Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers

乳腺癌中Fascin和DNA拓扑异构酶2-α的表达：与组织学亚型和其他预后标志物的相关性

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms26073076

Sánchez-Espinosa, Alberto; García-Rodríguez, José; Alonso-Aguirre, Virginia; Acosta-Ortega, Jesús María; Conesa-Zamora, Pablo; García-Solano, José; Luengo-Gil, Ginés

Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer

临床和免疫病理学评估及其与结直肠癌IHC共识分子亚型的比较

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-04962-w

Feliciangeli, Eduardo; Albaladejo-González, Ana; García-Rodríguez, José; Lázaro-Sánchez, Antonio; Borg, Rosanna; Pimentel-Cáceres, Paola; Soriano-Polo, Diego; Rodríguez-Braun, Edith; Balsalobre-Yago, José; Martínez-Ortiz, María José; Wikström-Fernández, Sofía; Murillo-Herrera, Andrés; García-García, Teresa; García-Solano, José; Conesa-Zamora, Pablo; Luengo-Gil, Ginés

Effectiveness and Safety of Sacituzumab Govitecan in Real-World Clinical Practice in Patients with Metastatic Triple-Negative and HR+/HER2-Negative Breast Cancer

Sacituzumab Govitecan 在转移性三阴性及 HR+/HER2 阴性乳腺癌患者真实世界临床实践中的有效性和安全性

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13092059

Lago-Ballester, Fernando; Martínez-Orea, Adrián; Laorden-Carrasco, Ana; Díaz-Carrasco, María Sacramento; Titos-Arcos, José Carlos; Mira-Sirvent, María Carmen; Luengo-Gil, Ginés; Martínez-Penella, Mónica

Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer.

从大型化学库中发现 Z1362873773：一种用于治疗结直肠癌的新型 fascin 抑制剂

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-96457-x

RodrÃguez-MartÃnez Alejandro, Giraldo-Ruiz LucÃa, Ramos MarÃa C, Luque Irene, Ribeiro Diogo, Postigo-Corrales FÃ¡tima, Alburquerque-GonzÃ¡lez BegoÃ±a, Montoro-GarcÃa Silvia, Arroyo-RodrÃguez Ana BelÃ©n, Conesa-Zamora Pablo, Hurtado Ana MarÃa, Luengo-Gil GinÃ©s, PÃ©rez-SÃ¡nchez Horacio

Safety and Effectiveness of Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Posterior Fossa Brain Metastases: A Single-Centre Experience

容积调强弧形放射治疗立体定向放射外科治疗后颅窝脑转移瘤的安全性和有效性：单中心经验

期刊:Journal of Clinical Medicine

影响因子:2.9

doi:10.3390/jcm14238540

Sánchez-Villalobos, José Manuel; Serna-Berna, Alfredo; Salinas-Ramos, Juan; Escolar-Pérez, Pedro Pablo; Luengo-Gil, Ginés; Andreu-Gálvez, Marina; Martínez-Alonso, Emma; Alcaraz, Miguel

神经科学

发表日期：2025

文献求助收藏

A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

一种包含免疫生物标志物、基因组增殖肿瘤标志物（AURKA 和 MYBL2）以及临床病理特征的新型预后模型，可优化新辅助乳腺癌患者的预后。

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2023.1182725

García-Torralba, Esmeralda; Navarro Manzano, Esther; Luengo-Gil, Gines; De la Morena Barrio, Pilar; Chaves Benito, Asunción; Pérez-Ramos, Miguel; Álvarez-Abril, Beatriz; Ivars Rubio, Alejandra; García-Garre, Elisa; Ayala de la Peña, Francisco; García-Martínez, Elena

Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry

晚期胃癌患者血栓相关基因的鉴定：来自AGAMENON-SEOM注册研究的数据

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines10010148

Zaragoza-Huesca, David; Garrido-Rodríguez, Pedro; Jiménez-Fonseca, Paula; Martínez de Castro, Eva; Sánchez-Cánovas, Manuel; Visa, Laura; Custodio, Ana; Fernández-Montes, Ana; Peñas-Martínez, Julia; Morales Del Burgo, Patricia; Gallego, Javier; Luengo-Gil, Ginés; Vicente, Vicente; Martínez-Martínez, Irene; Carmona-Bayonas, Alberto

Pleiotropic Effects of the P5-Type ATPase SpfA on Stress Response Networks Contribute to Virulence in the Pathogenic Mold Aspergillus fumigatus

P5 型 ATPase SpfA 对应激反应网络的多效性影响导致致病霉菌烟曲霉的毒力

期刊:mBio

影响因子:5.1

doi:10.1128/mBio.02735-21

José P Guirao-Abad #, Martin Weichert #, Ginés Luengo-Gil, Sarah Sze Wah Wong, Vishukumar Aimanianda, Christina Grisham, Nikita Malev, Shivani Reddy, Laura Woollett, David S Askew

发表日期：2021

文献求助收藏

Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review

CAR-M疗法在实体瘤治疗中的强大潜力：一项综合综述

Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions

多西他赛耐药性在乳腺癌中的应用：现状与未来展望

Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers

乳腺癌中Fascin和DNA拓扑异构酶2-α的表达：与组织学亚型和其他预后标志物的相关性

Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer

临床和免疫病理学评估及其与结直肠癌IHC共识分子亚型的比较

Effectiveness and Safety of Sacituzumab Govitecan in Real-World Clinical Practice in Patients with Metastatic Triple-Negative and HR+/HER2-Negative Breast Cancer

Sacituzumab Govitecan 在转移性三阴性及 HR+/HER2 阴性乳腺癌患者真实世界临床实践中的有效性和安全性

Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer.

从大型化学库中发现 Z1362873773：一种用于治疗结直肠癌的新型 fascin 抑制剂

Safety and Effectiveness of Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Posterior Fossa Brain Metastases: A Single-Centre Experience

容积调强弧形放射治疗立体定向放射外科治疗后颅窝脑转移瘤的安全性和有效性：单中心经验

A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

一种包含免疫生物标志物、基因组增殖肿瘤标志物（AURKA 和 MYBL2）以及临床病理特征的新型预后模型，可优化新辅助乳腺癌患者的预后。

Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry

晚期胃癌患者血栓相关基因的鉴定：来自AGAMENON-SEOM注册研究的数据

Pleiotropic Effects of the P5-Type ATPase SpfA on Stress Response Networks Contribute to Virulence in the Pathogenic Mold Aspergillus fumigatus

P5 型 ATPase SpfA 对应激反应网络的多效性影响导致致病霉菌烟曲霉的毒力